Patents by Inventor Aguan Wei

Aguan Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of inhibitors of the KQT1 channel and methods of controlling and treating diseases caused by helminths and ectoparasites
    Publication number: 20020055537
    Abstract: Use of inhibitors of the KQT1 channel for preparing a medicament for treating diseases caused by helminths and ectoparasites
    Type: Application
    Filed: November 16, 2001
    Publication date: May 9, 2002
    Applicant: Aventis Pharma Deutschland GMBH
    Inventors: Uwe Gerlach, Joachim Hofmann, Hans Jochen Lang, Aguan Wei
  • Use of inhibitors of the KQTI channel and methods of controlling and treating diseases caused by helminths and ectoparasites
    Patent number: 6335363
    Abstract: Use of inhibitors of the KQT1 channel for preparing a medicament for treating diseases caused by helminths and ectoparasites Inhibitors of the KQT1 channel are a novel way of destroying helminths and ectoparasites. For this reason, blockers of the cellular KQT1 channel, which is present in helminths and ectoparasites, are used for preparing a medicament for the treatment of vertebrates and humans infested by helminths or ectoparasites. These KQT1 blockers are used as medicaments on their own or in combination with other medicaments and therapeutic measures. Inhibitors of the KQT1 channel are likewise a novel mechanism of action for phytoparasites such as insects, arachnids, molluscs and nematodes, and consequently, they are used for preparing a crop protection composition.
    Type: Grant
    Filed: December 16, 1999
    Date of Patent: January 1, 2002
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Uwe Gerlach, Joachim Hofmann, Hans Jochen Lang, Aguan Wei